Top 25 Publications from FY17 Based on Impact Factor

  1. Almoguera B; Vazquez L; Mentch F; Connolly J; Pacheco JA; Sundaresan AS; Peissig PL; Linneman JG; McCarty CA; Crosslin D. Identification of Four Novel Loci in Asthma in European American and African American Populations. American journal of respiratory and critical care medicine. 2017; 195:456-463.
  2. Yang IV; Pedersen BS; Liu AH; O'Connor GT; Pillai D; Kattan M; Misiak RT; Gruchalla R; Szefler SJ; Khurana Hershey GK. The nasal methylome and childhood atopic asthma. Journal of Allergy and Clinical Immunology. 2017; 139:1478-1488.
  3. Trivedi A; Hall C; Hoffman EA; Woods JC; Gierada DS; Castro M. Using imaging as a biomarker for asthma. Journal of Allergy and Clinical Immunology. 2017; 139:1-10.
  4. Hysinger EB; Roizen JD; Mentch FD; Vazquez L; Connolly JJ; Bradfield JP; Almoguera B; Sleiman PM; Allen JL; Levine MA. Mendelian randomization analysis demonstrates that low vitamin D is unlikely causative for pediatric asthma. Journal of Allergy and Clinical Immunology. 2016; 138:1747-1749.e4.
  5. Pongracic JA; Krouse RZ; Babineau DC; Zoratti EM; Cohen RT; Wood RA; Khurana Hershey GK; Kercsmar CM; Gruchalla RS; Kattan M. Distinguishing characteristics of difficult-to-control asthma in inner-city children and adolescents. Journal of Allergy and Clinical Immunology. 2016; 138:1030-1041.
  6. Liu AH; Babineau DC; Krouse RZ; Zoratti EM; Pongracic JA; O'Connor GT; Wood RA; Khurana Hershey GK; Kercsmar CM; Gruchalla RS. Pathways through which asthma risk factors contribute to asthma severity in inner-city children. Journal of Allergy and Clinical Immunology. 2016; 138:1042-1050.
  7. Zoratti EM; Krouse RZ; Babineau DC; Pongracic JA; O'Connor GT; Wood RA; Khurana Hershey GK; Kercsmar CM; Gruchalla RS; Kattan M. Asthma phenotypes in inner-city children. Journal of Allergy and Clinical Immunology. 2016; 138:1016-1029.
  8. Perrin EC; Leslie LK; Boat T. Parenting as Primary Prevention. JAMA Pediatrics. 2016; 170:637-638.
  9. Spielberg DR; Clancy JP. Cystic Fibrosis and Its Management Through Established and Emerging Therapies. Annual Review of Genomics and Human Genetics. 2016; 17:155-175.
  10. Xu X; Abdalla T; Bratcher PE; Jackson PL; Sabbatini G; Wells JM; Lou XY; Quinn R; Blalock JE; Clancy JP. Doxycycline improves clinical outcomes during cystic fibrosis exacerbations. The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology. 2017; 49:1601102.
  11. Muhlebach MS; Beckett V; Popowitch E; Miller MB; Baines A; Mayer-Hamblett N; Zemanick ET; Hoover WC; Vandalfsen JM; Campbell P. Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial. Thorax. 2017; 72:318-326.
  12. Kimura N; Khan MS; Schecter M; Rizwan R; III BR; Wells E; Towe C; Zafar F; Morales DLS. Changing demographics and outcomes of lung transplantation recipients with cystic fibrosis. Journal of Heart and Lung Transplantation. 2016; 35:1237-1244.
  13. Campo I; Luisetti M; Griese M; Trapnell BC; Bonella F; Grutters JC; Nakata K; Van Moorsel CHM; Costabel U; Cottin V. A Global Survey on Whole Lung Lavage in Pulmonary Alveolar Proteinosis. Chest. 2016; 150:251-253.
  14. Taylor HG; Bowen SR; Beebe DW; Hodges E; Amin R; Arens R; Chervin RD; Garetz SL; Katz ES; Moore RH. Cognitive Effects of Adenotonsillectomy for Obstructive Sleep Apnea. Pediatrics. 2016; 138:e20154458.
  15. Batalden M; Batalden P; Margolis P; Seid M; Armstrong G; Opipari-Arrigan L; Hartung H. Coproduction of healthcare service. BMJ Quality and Safety. 2016; 25:509-517.
  16. Giridhar PV; Bell SM; Sridharan A; Rajavelu P; Kitzmiller JA; Na CL; Kofron M; Brandt EB; Ericksen M; Naren AP. Airway Epithelial KIF3A Regulates Th2 Responses to Aeroallergens. Journal of immunology (Baltimore, Md. : 1950). 2016; 197:4228-4239.
  17. Downes KJ; Dong M; Fukuda T; Clancy JP; Haffner C; Bennett MR; Vinks AA; Goldstein SL. Urinary kidney injury biomarkers and tobramycin clearance among children and young adults with cystic fibrosis: a population pharmacokinetic analysis. Journal of Antimicrobial Chemotherapy. 2017; 72:254-260.
  18. Smith DF; Hossain MM; Hura A; Huang G; McConnell K; Ishman SL; Amin RS. Inflammatory Milieu and Cardiovascular Homeostasis in Children With Obstructive Sleep Apnea. Sleep. 2017; 40.
  19. Ehsan Z; Ishman SL; Kimball TR; Zhang N; Zou Y; Amin RS. Longitudinal Cardiovascular Outcomes of Sleep Disordered Breathing in Children: A Meta-Analysis and Systematic Review. Sleep. 2017; 40.
  20. Cleveland ZI; Zhou YM; Akinyi TG; Dunn RS; Davidson CR; Guo J; Woods JC; Hardie WD. Magnetic resonance imaging of disease progression and resolution in a transgenic mouse model of pulmonary fibrosis. American journal of physiology. Lung cellular and molecular physiology. 2017; 312:L488-L499.
  21. Arora K; Yarlagadda S; Zhang W; Moon C; Bouquet E; Srinivasan S; Li C; Stokes DC; Naren AP. Personalized medicine in cystic fibrosis: genistein supplementation as a treatment option for patients with a rare S1045Y-CFTR mutation. American journal of physiology. Lung cellular and molecular physiology. 2016; 311:ajplung.00134.2016-ajplung.00134.2016.
  22. Leslie LK; Mehus CJ; Hawkins JD; Boat T; McCabe MA; Barkin S; Perrin EC; Metzler CW; Prado G; Tait VF. Primary Health Care Potential Home for Family-Focused Preventive Interventions. American Journal of Preventive Medicine. 2016; 51:S106-S118.
  23. Madala SK; Sontake V; Edukulla R; Davidson CR; Schmidt S; Hardie WD. Unique and Redundant Functions of p70 Ribosomal S6 Kinase Isoforms Regulate Mesenchymal Cell Proliferation and Migration in Pulmonary Fibrosis. American journal of respiratory cell and molecular biology. 2016; 55:792-803.
  24. Wong BL; Rybalsky I; Shellenbarger KC; Tian C; McMahon MA; Rutter MM; Sawnani H; Jefferies JL. Long-Term Outcome of Interdisciplinary Management of Patients with Duchenne Muscular Dystrophy Receiving Daily Glucocorticoid Treatment. The Journal of Pediatrics. 2017; 182:296-303.e1.
  25. Clancy JP; Benitez DS; Fajac I; Jain M; Rowe SM; Sawicki G. Applying recent advances in the science of CFTR-based therapeutics to improve outcomes in patients with cystic fibrosis. Journal of Cystic Fibrosis. 2017; 16:e9-e10.